J B Chemicals and Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹1,811.10(0.78%)December 10, 2025 15:26:33 PM IST
- NSE
- BSE
- Vol : 330.04 K (NSE + BSE)Last 20 day avg : 156.56 K
J B Chemicals and Pharmaceuticals is trading 0.78% upper at Rs 1,811.10 as compared to its last closing price. J B Chemicals and Pharmaceuticals has been trading in the price range of 1,820.45 & 1,776.50. J B Chemicals and Pharmaceuticals has given -2.45% in this year & 1.96% in the last 5 days. J B Chemicals and Pharmaceuticals has TTM P/E ratio 37.08 as compared to the sector P/E of 28.32.There are 11 analysts who have initiated coverage on J B Chemicals and Pharmaceuticals. There are 5 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 207.82 Crores in its last quarter.Listed peers of J B Chemicals and Pharmaceuticals include Dr Reddy's Laboratories (0.28%), Divi's Laboratories (-0.09%), Sun Pharmaceutical Industries (0.75%).The Mutual Fund holding in J B Chemicals and Pharmaceuticals was at 19.15% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in J B Chemicals and Pharmaceuticals was at 15.31% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Dec 10, 2025, 09:29 PM UTC
- BetaLow volatility0.42Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.86Annual dividends as a percentage of the stock price.
- P/BLower than historical values8.16The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values39.78Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation2.14The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Dr Reddy's Laboratories | Moderately Bearish | 1,249.70 | 0.28 | 1,04,118.11 | 18.80 | 3.17 | 0.63 | 2.34 |
| Divi's Laboratories | Moderately Bearish | 6,286.55 | -0.09 | 1,66,866.93 | 78.27 | 11.47 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,789.45 | 0.75 | 4,29,278.10 | 37.94 | 6.04 | 0.88 | 0.50 |
| Cipla | Bearish | 1,489.15 | -0.10 | 1,20,289.25 | 23.33 | 3.94 | 0.85 | 0.81 |
| Torrent Pharmaceuticals | Bullish | 3,794.00 | 0.82 | 1,28,522.29 | 66.64 | 16.92 | 0.84 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-11 | Quarterly Results |
| 2025-07-30 | Quarterly Results |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-04 | Quarterly Results & Interim Dividend |
| 2024-11-06 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE572A01036
- BSE Code506943
- NSE CodeJBCHEPHARM
J B Chemicals and Pharmaceuticals is trading at 1811.10 as on Wed Dec 10 2025 09:56:33. This is 0.78% upper as compared to its previous closing price of 1797.00.
The market capitalization of J B Chemicals and Pharmaceuticals is 28356.40 Cr as on Wed Dec 10 2025 09:56:33.
The average broker rating on J B Chemicals and Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 5 analysts have given a strong buy rating
- 3 analysts have given a buy rating
- 3 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for J B Chemicals and Pharmaceuticals is 1950.30 whereas the 52 wk low is 1303.00
J B Chemicals and Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 37.08
- Sector P/E: 28.32
- Dividend Yield: 0.86%
- D/E ratio: 0.01
J B Chemicals and Pharmaceuticals reported a net profit of 659.58 Cr in 2025.
The Mutual Fund Shareholding was 19.15% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
J B Chemicals and Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.